LONZA GROUP LTD Chart calendar Lonza Group Ltd
85c88c479b44c4.7Tg9FoiHM6T55pnNL4xha1pgp2hXNMjZZS5dNvJvyJw.hnoQU8LoAdKmjvj6YuFRHTQH0lggRZC1Jns4ZcQm8dqnT1JD8sQAicHQoQ~0e015d7e70bc7c19cb26de30708ec882
Upcoming events on Lonza Group Ltd
Past events on Lonza Group Ltd
| 12/05/2024 | Détachement de for final dividend |
| 12/05/2024 | Détachement de for Distribution from share premium account |
| 08/05/2024 09:00 | Annual General Meeting |
| 26/03/2024 15:00 | Business Update Call |
| 20/03/2024 13:00 | Acquisition of Large-Scale Biologics Site in Vacaville from Roche by Lonza Call |
| 26/01/2024 13:00 | Q4 2023 Earnings Call |
| 25/01/2024 | Q4 2023 Earnings Release |
| 09/01/2024 21:30 | JP Morgan Healthcare Conference |
| 03/01/2024 | Shareholders Meeting |
| 28/11/2023 | Nordic Life Sciences Day |
| 17/10/2023 08:30 | Capital Markets Day |
| 21/07/2023 13:00 | Q2 2023 Earnings Call |
| 21/07/2023 06:00 | Q2 2023 Earnings Release |
| 08/05/2023 | Détachement de for final dividend |
| 08/05/2023 | Détachement de for Distribution from share premium account |
| 05/05/2023 09:00 | Annual General Meeting |
| 25/01/2023 13:00 | FY 2022 Earnings Call |
| 24/01/2023 | FY 2022 Earnings Release |
| 11/01/2023 18:30 | JP Morgan Healthcare Conference |
| 27/09/2022 | Citi European HC Bus Tour |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CHF | Released Forecast Spread | 5 920 5 897 0.4% | 6 185 6 161 0.39% | 5 409 5 187 4.28% | 6 223 6 189 0.55% | 6 717 6 512 3.14% | 6 661 |
|
EBITDA Million CHF | Released Forecast Spread | 1 624 1 615 0.57% | 1 728 1 696 1.91% | 1 665 1 654 0.66% | 1 995 1 936 3.03% | 1 999 1 899 5.26% | 1 826 |
|
EBIT Million CHF | Released Forecast Spread | 1 249 1 218 2.58% | 1 358 1 310 3.65% | 1 151 1 184 -2.79% | 1 397 1 372 1.85% | 939 1 263 -25.66% | 1 169 |
|
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | 849 885 -4.04% | 986 981 0.51% | 760 847 -10.23% | 1 448 1 194 21.26% | 790 1 140 -30.71% | 1 091 |
|
Net income Million CHF | Released Forecast Spread | 645 720 -10.44% | 869 844 2.92% | 2 944 1 376 113.89% | 1 215 1 046 16.18% | 654 944 -30.7% | 893 |
|
EPS CHF | Released Forecast Spread | 8,65 9,68 -10.66% | 11,6 11,6 0.61% | 39,5 18,9 108.65% | 16,3 14,1 16.05% | 8,88 12,8 -30.77% | 12,4 |
| Announcement Date | 21/01/20 | 27/01/21 | 26/01/22 | 25/01/23 | 26/01/24 | - |
Quarterly results
| Fiscal Period | December | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CHF | Released Forecast Spread | 2 944 2 907 1.26% | 3 074 3 080 -0.2% | 3 111 3 086 0.8% | 2 542 2 474 2.74% | 2 867 2 650 8.18% | 2 982 2 965 0.58% | 3 241 3 201 1.25% | 3 078 3 168 -2.85% | 3 639 3 440 5.77% | 3 032 | 3 643 |
|
EBITDA Million CHF | Released Forecast Spread | 796 783 1.66% | 893 848 5.36% | 835 813 2.72% | 847 778 8.91% | 818 813 0.63% | 987 930 6.11% | 1 008 984 2.49% | 922 933 -1.23% | 1 077 988 8.98% | 801 | 1 038 |
|
EBIT Million CHF | Released Forecast Spread | 606 581 4.26% | 706 637 10.76% | 652 608 7.33% | 606 607 -0.12% | 545 613 -11.14% | 698 680 2.59% | 699 703 -0.6% | 563 619 -9.09% | 376 670 -43.86% | 503 | 700 |
|
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | 407 424 -4.03% | 564 479 17.87% | 422 467 -9.6% | 296 476 -37.81% | 464 525 -11.64% | 594 637 -6.81% | 854 667 28% | 486 556 -12.62% | 304 608 -50.02% | 442 | 646 |
|
Net income Million CHF | Released Forecast Spread | 346 339 2.19% | 477 399 19.65% | 392 391 0.17% | 319 414 -23.01% | 2 625 2 466 6.45% | 492 539 -8.74% | 723 537 34.55% | 410 465 -11.88% | 244 511 -52.26% | 366 | 532 |
|
EPS CHF | Released Forecast Spread | 4,64 4,70 -1.17% | 6,39 5,35 19.38% | 5,24 5,16 1.58% | 4,28 5,50 -22.13% | 35,2 33,1 6.56% | 6,61 7,12 -7.21% | 9,73 7,19 35.28% | 5,54 6,21 -10.79% | 3,34 6,95 -51.93% | 4,99 | 7,27 |
| Announcement Date | 21/01/20 | 24/07/20 | 27/01/21 | 23/07/21 | 26/01/22 | 22/07/22 | 25/01/23 | 21/07/23 | 26/01/24 | - | - |
| 15/07/2024 06:45 | ADDLIFE AB: Q2 2024 Earnings Release |
| 21/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 23/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 25/07/2024 06:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 25/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 26/07/2024 06:00 | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Lonza Group Ltd
| 07/06/2024 07:57 | POLARIS GROUP: May 2024 Sales and Revenue Release |
| 29/05/2024 21:01 | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 23/05/2024 12:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
| 22/05/2024 06:00 | EVOTEC SE: Q1 2024 Earnings Release |
| 21/05/2024 22:14 | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 12:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 17/05/2024 07:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
| 15/05/2024 21:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 12:00 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |